Plug and Play Health’s Post

The specific challenges have now been identified. Are you a start-up or innovator that has a solution for one ore more of these challenges? If so, we want to hear from you!

Day 1 at DMEA - Connecting Digital Health and super excited! Point 1: The industry is developing rapidly due to the demand for more affordable and faster medicine. Point 2: I've already seen several startups that have the potential to make a serious impact on the industry and change it for the better. More on that later. Point 3: The people here are wonderful. For those who haven't had a chance to schedule a meeting with me here yet, I welcome you. Let's discuss your ideas and ways to implement it. #techCEO #DMEA2024 #medtechweek #medtechknows #healthcareinnovation #healthtechstartup

Innovating Healthcare in a Post-Covid World: Join the InnovatorMD Startup Showcase! Join us on May 16th for the InnovatorMD Startup Showcase, where we'll be featuring Vivek Narayan, Director of Products at Recoup Health. RECOUP Health is revolutionizing healthcare by offering an innovative, integrative approach to rehabilitation. Their unique blend of in-clinic and app-based services tackles chronic diseases, mood disorders, and more, all while leveraging technology to improve global health outcomes. Vivek is a passionate leader dedicated to using technology to solve healthcare challenges. His expertise lies in aligning business strategy with product development and operations. Don't miss this opportunity to learn from a healthcare innovator! Register for the InnovatorMD Startup Showcase: https://lnkd.in/gxZxt-ga Uli K. Chettipally, MD., MPH., Suzy Engwall, Lavinia Herbei, MD, MBA, Dominique Kim, MPH, Nila Rafiq, MD, MBA, Suchet Sarda MD, FACP, MMM, CPE #healthcare #innovation #RECOUPHealth #startup #digitalhealth #postcovid

🎉 Exciting News this week from Cacta ApS! 🎉 We're thrilled to announce that Cacta ApS has been selected to participate in Femovate by Guidea! We were selected from 130 startups across 6 continents because of our potential to positively impact women’s health and wellness in a critical area of femtech!   🚀 About the Sponsorship Femovate by Guidea provides expert UX research and design services for early stage femtech startups to give a small but powerful boost for companies like ours to shape the future of women’s health and wellness with well designed products and services.   🌟 Why It Matters Research from the World Economic Forum found that women-focused research could yield an economic return of over 40 times its investment. Femovate by Guidea’s support for Cacta ApS and the other selected startups has the potential to revolutionize access to healthcare globally–save lives, close health equity gaps, establish culturally sensitive care standards, and dramatically bolster the quality of life for women and people who are AFAB.   ❤️The support from Femovate by Guidea Programme truly fuels our mission to support the women affected by breast cancer-related treatment effects. We believe that early detection with home-monitoring device - MyLymphCare and timely treatment is the key to decrease chronic secondary lymphedema.   Thank you to Karin Dahlstrom and Theresa Neil and the Guidea team as well as Ida Tin and Erin Gallagher. We are eager to start working with you.   🏅 Learn More Read the Press Release Meet the startups selected for femovate 2023-24    #femtech #womenshealth #healthtech #digitalhealth #healthcare #healthcareinnovation #startups #innovation #health #medtech #healthcareresearch #femalehealth #genderhealthgap #funding #investment #healthequity

Great "Always Forward" insights from Joe Urban truly a CEO that exemplifies Transformational Leadership. By definition, Transformational Leadership is, the ability of leaders to motivate and inspire employees and effect positive changes in groups. Effective transformational leaders are emotionally intelligent, energetic and passionate. Those who know Joe know he embodies EQ with energy that is off the charts!

Yesterday was a stimulating day dedicated to orchestrating the expansion of the HITLAB Breakthrough Alliance Europe, aimed at propelling the growth of European digital health startups in the US and vice versa. Commencing with the outline of our ambitious 2024 strategy and transitioning into enriching dialogues with field experts from both sides of the Atlantic, the boundless prospects within the digital health domain became apparent. It was delightful to champion HITLAB's breakthrough alliance expansion in Europe, seizing a distinct opportunity to engage with pivotal collaborators and trailblazers from the US and European healthcare sectors. Collectively, we forge connections, dismantle obstacles, and sculpt the future of healthcare. #digitalhealth #certiscan #NYCHIW2024

🌟 Exciting News from Apixmed! 🌟 Delighted to share that Apixmed is not only attending but also presenting at the Lviv Startup IT Arena! 🚀 At Apixmed, we're not just in the business of healthcare technology; we're dedicated to transforming lives through personalized medicine solutions. Our mission is to tailor healthcare experiences, making them as unique and individual as each patient. In a world inundated with generic solutions, we stand out by embracing the power of personalization. Our team has poured passion, innovation, and countless hours into creating groundbreaking solutions that redefine patient care. We understand that every individual is unique, and their healthcare journey should reflect that. Our focus on personalized medicine is not just a strategy; it's our commitment to humanize healthcare, one tailored solution at a time. As we take the stage at Lviv Startup IT Arena, our goal is clear: we're here to find partners who share our vision. We believe that collaboration is the key to unlocking unprecedented potential. We're on the lookout for like-minded innovators, forward-thinking healthcare professionals, and visionary investors who understand the transformative power of personalized medicine. So, if you're at Lviv Startup IT Arena, come meet us at our booth. Let's talk about how we can revolutionize healthcare together. Let's explore the possibilities of collaboration, where your vision meets our expertise, and together, we create a future where healthcare isn't just about treating illnesses; it's about celebrating individuality and enhancing lives. Thank you to the organizers for providing this platform, and here's to forging meaningful partnerships that will shape the future of personalized healthcare! #ITArena #ITArena2023 #StartupCompetition2023 #StartupCompetitionUkraine #Apixmed #PersonalizedMedicine #HealthcareInnovation #StartupITArena #Collaboration #FutureofHealthcare #InnovateWithUs 🌍✨

Thrilled to witness the official launch of One2Treat! I'm eager to see how this innovative approach in clinical treatment assessment may transform the biopharma industry. Having seen its evolution during its incubation within IDDI over the past year, I can testify about One2Treat's dedication to patient-centricity. One2Treat’s digital solutions has the potential to bring broad impact on clinical trial designs, incorporating all key patient-relevant outcomes within a single primary analysis. This typically helps reduce the sample size by 20% and consequently the patient recruitment timelines. #Patientcentricity #Innovation #TrialDesign

There is enormous value being in-country, talking with potential clients, re-sellers, corporate partners as well as checking-in with existing stakeholders. Market growth can't be done at a distance. Thanks once again to all our #Paris based counterparts who made the week a success and looking forward to building on our conversations. #goingglobal #businessexpansion

“You've got to balance the idea that the doctors that first work with you are going to understand that they have technology that isn't complete, that this isn't the final generation. But you need to have developed it in such a way that there is a real path to that final version.” Dan Rose is back on Medsider to share his proven #medtech insights after LimFlow SA’s recent exit to Inari Medical. With 25 years of experience in both startups and industry giants like Medtronic, Dan talks about M&A transactions, engaging with investors while maintaining business autonomy, and the importance of developing your #medicaldevice with the average user in mind. LimFlow’s technology tackles Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI) – conditions where blocked arteries threaten limb viability and may potentially lead to amputation. Instead of trying to open blockages, LimFlow ingeniously reroutes blood flow through adjacent veins, restoring circulation and offering hope to patients who suffer from this disease. Here’s a sneak peek into his interview with Scott Nelson: ⚖️ Vet your potential investors carefully and consider how their involvement will impact your business operations, especially if there are multiple parties involved. Limit their influence on decision-making to maintain flexibility and control over your company's direction. 🥼 In the early development phases, design for the average user to maximize adoption rates. Always iterate towards simplicity and be prepared to pivot accordingly. And don't hold onto complex elements or features simply because they were part of the original plan. 💵 Understanding the reimbursement landscape and how your technology fits into that is crucial to progress your conversations with VCs. Research potential investors to ensure that they have the capacity to invest and that their interests match your company's focus. Click on the link in the comments section to follow Dan’s journey building and exiting LimFlow. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We just launched Medsider Mentors Volume V, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.